| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 35.2K | $2.71M | $77.05 | May 21, 2024 | Direct |
| Embecta Corp. | Director | Common Stock | 39.7K | $743K | $18.70 | Feb 12, 2025 | Direct |
| CARMAX INC | Director | Common Stock | 7.77K | $548K | $70.54 | Jul 2, 2021 | Direct |
| HENRY SCHEIN INC | Director | Common Stock par value $0.01 per share | 2.84K | $200K | $70.31 | Mar 4, 2025 | Direct |
| Aptinyx Inc. | Director | Common Stock | 229K | Nov 12, 2021 | Direct | ||
| Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
| HENRY SCHEIN INC | Director | No Securities Beneficially Owned | 0 | Jan 29, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HSIC | HENRY SCHEIN INC | Mar 4, 2025 | 1 | $0 | 4 | Mar 6, 2025 | Director |
| EMBC | Embecta Corp. | Feb 12, 2025 | 1 | $0 | 4 | Feb 14, 2025 | Director |
| HSIC | HENRY SCHEIN INC | Jan 29, 2025 | 0 | $0 | 3 | Feb 5, 2025 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| EMBC | Embecta Corp. | Feb 7, 2024 | 1 | $0 | 4 | Feb 9, 2024 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 23, 2023 | 1 | $0 | 4 | May 24, 2023 | Director |
| EMBC | Embecta Corp. | Feb 9, 2023 | 1 | $0 | 4 | Feb 10, 2023 | Director |
| APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| EMBC | Embecta Corp. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |
| EMBC | Embecta Corp. | Mar 20, 2022 | 0 | $0 | 3 | Mar 21, 2022 | Director |
| APTX | Aptinyx Inc. | Nov 11, 2021 | 2 | $192K | 4/A | Nov 16, 2021 | Director |
| KMX | CARMAX INC | Jul 2, 2021 | 1 | $0 | 4 | Jul 7, 2021 | Director |
| APTX | Aptinyx Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |